Literature DB >> 16672880

Distal femur replacement is useful in complex total knee arthroplasty revisions.

Richard J Harrison1, Mihir M Thacker, J David Pitcher, H Thomas Temple, Sean P Scully.   

Abstract

UNLABELLED: Revision total knee arthroplasty can be considerably more difficult in cases involving severe bone loss, complete absence of collateral ligaments, and persistent periprosthetic supracondylar femoral fractures. Modular segmental endoprosthetic distal femur replacement is a limb salvage option when other surgical options are unfeasible. The clinical performance of rotating hinge knee prostheses has greatly improved with the evolution of second and third generation designs. The increased freedom of rotation decreases the prosthetic bone stresses and the longevity. While designs have improved, the prostheses still do not match the function and longevity of condylar components with approximately a 90% survivorship at 20 years. The modular endoprosthesis rotating hinge knee prosthesis is useful for total knee arthroplasty revision in patients with inadequate bone stock, ligamentous instability, or difficult supracondylar femur fractures, especially in low demand elderly patients. LEVEL OF EVIDENCE: Therapeutic study, level V (expert opinion). See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2006        PMID: 16672880     DOI: 10.1097/01.blo.0000214433.64774.1b

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Revision of broken knee megaprostheses: new solution to old problems.

Authors:  Manish Agarwal; Ashish Gulia; B Ravi; Rupesh Ghyar; Ajay Puri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

Review 2.  Megaprostheses in the treatment of periprosthetic fractures of the knee joint: indication, technique, results and review of literature.

Authors:  Reinhard Windhager; Markus Schreiner; Kevin Staats; Sebastian Apprich
Journal:  Int Orthop       Date:  2015-09-25       Impact factor: 3.075

Review 3.  Surgical treatment options in patients with impaired bone quality.

Authors:  Norman A Johanson; Jody Litrenta; Jay M Zampini; Frederic Kleinbart; Haviva M Goldman
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

4.  Revision knee arthroplasty using a distal femoral replacement prosthesis for periprosthetic fractures in elderly patients.

Authors:  Ehab Girgis; Christoph McAllen; Jonathan Keenan
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-07-01

5.  The linea aspera as a rotational landmark: an anatomical MRI-based study.

Authors:  Gustavo Reple; Arnaud Felden; Antoine Feydy; Philippe Anract; David Biau
Journal:  Surg Radiol Anat       Date:  2016-03-12       Impact factor: 1.246

6.  A tumor endoprosthesis is useful in elderly rheumatoid arthritis patient with acute intercondylar fracture of the distal femur.

Authors:  Hiroki Wakabayashi; Yohei Naito; Masahiro Hasegawa; Tomoki Nakamura; Akihiro Sudo
Journal:  Rheumatol Int       Date:  2011-03-26       Impact factor: 2.631

Review 7.  Management of infected extremity endoprostheses: a systematic review.

Authors:  Nicholas Nucci; Aaron Gazendam; Kyle Gouveia; Michelle Ghert; David Wilson
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-05-13

Review 8.  Periprosthetic fractures of the femur after total knee arthroplasty.

Authors:  Phil McGraw; Arun Kumar
Journal:  J Orthop Traumatol       Date:  2010-07-27

9.  Length of Endoprosthetic Reconstruction in Revision Knee Arthroplasty Is Associated With Complications and Reoperations.

Authors:  Jeffrey J Barry; Zachary Thielen; David C Sing; Paul H Yi; Erik N Hansen; Michael Ries
Journal:  Clin Orthop Relat Res       Date:  2017-01       Impact factor: 4.176

10.  Loss of distal femur combined with popliteal artery occlusion: reconstructive arthroplasty using modular segmental endoprosthesis: a case report.

Authors:  Shin-Taeg Kang; Chan-Ha Hwang; Bo-Hyeon Kim; Byung-Yoon Sung
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.